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Periodontitis is a disease of infectious aetiology that causes inflammatory destruction of the tooth-supporting tissues. Activated T-cells are central to the pathogenesis of the disease, by producing Receptor activator of NF-? B ligand (RANKL) that stimulates bone resorption. Antigenic activation of T-cells is regulated by the induction of transcription factor Nuclear Factor of Activated T cells, cytoplasmic 1 (NFATc1).
There is as yet no information on the potential involvement of NFATc1 in periodontal diseases. This study aimed to investigate NFATc1 gene expression levels in periodontal diseases, and analyse the potential correlation with RANKL expression and clinical periodontal parameters. In this cross-sectional study, gingival tissue biopsies were obtained from healthy (n = 10) and periodontally diseased (n = 58) sites. NFATc1 and RANKL gene expression levels in these samples were analysed by quantitative real-time polymerase chain reaction. Compared to healthy subjects, patients with gingivitis, chronic and aggressive periodontitis, exhibited higher NFATc1 expression, which proved to be statistically significant in the periodontitis groups. NFATc1 and RANKL expression levels strongly correlated with each other, and with clinical periodontal parameters. The increased expression of NFATc1 in
I NT RODUCT I ON
Periodontitis is characterised by loss of connective tissue attachment and alveolar bone destruction, as a result of inflammation triggered by bacterial biofilms attached on the tooth surface. If the disease is left untreated, it may eventually lead to tooth loss as a result of destruction of the supportive bone. The pathogenesis of the disease largely accounts for a host immune response to the bacterial infection, which is dominated by the presence of T-cells (1, 2). When recruited into the infected area, Tcells can induce bone resorption by producing Receptor Activator of NF-kB Ligand (RANKL), the key osteoclast differentiation cytokine belonging to the tumor necrosis factor ligand family. By activating its cognate RANK receptor on monocytes, RANKL triggers their fusion and differentiation into osteoclasts, an event that can be blocked by its soluble decoy receptor osteoprotegerin (OPG) (3, 4) . Activated T-cells appear to be the primary source of RANKL in diseased periodontal tissues (1, 2, 5, 6).
The recognition of bacterial antigens by immuno-receptors on T-cells leads to the production of T-cell-specific cytokines. This event is predominantly mediated by the inducible expression of transcription factor Nuclear Factor of Activated T cells, cytoplasmic 1 (NFATc1, also NFAT2) (7, 8) . This transcription factor is expressed at low levels in resting T-cells, but is strongly induced upon activation, in order to enhance and sustain the expression of genes crucial for peripheral T-cell development and function (9) . NFATc1 expression is also recently identified in differentiating osteoclasts and is considered to be the major intracellular regulator of osteoclastogenesis downstream of RANKL (10, 11) . The dendritic cell-specific transmembrane protein (DC-STAMP) is also induced in osteoclasts upon RANKL stimulation and is involved in their fusion and multi-nucleation (12) .
As there is as yet no clinical evidence available on the involvement of NFATc1 and DC-STAMP in periodontal diseases, the present cross-sectional study aimed to investigate their gene expression levels in gingival tissue samples of healthy and periodontally diseased subjects.
MAT E RI AL S AND ME T HODS S t u d y p o p u l a t i o n a n d c l i n i c a l e x a mi n a t i o n
A total of 58 subjects were included in this study, recruited from the Department of Periodontology, School of Dentistry, Ege University, I zmir (13) . The use of human subjects satisfied the requirements of Ege University Ethics Review Board, and was conducted in accordance to the Declaration of Helsinki. Written and informed consent was obtained from each subject prior to enrolment in the study. Patients were selected according to the clinical and radiographic criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions (14) .
Complete medical and dental histories were taken. None of the subjects had a history of systemic disease or cigarette smoking, and had not taken medications such as antibiotics or contraceptives that could affect their periodontal status for at least 3 months prior to the study. 
Co l l e c t i o n o f g i n g i v a l t i s s u e s a mp l e s
After screening, the patients were recalled for sampling, prior to entering any therapy phase. A single gingival tissue biopsy was taken from each patient, from interproximal sites of single rooted teeth by gingivectomy, under local anesthesia.
These biopsies included both gingival (junctional, crevicular or pocket) epithelium and gingival connective tissue. For the periodontitis groups, samples were collected from sites with clinical attachment loss = 5 mm prior to non-surgical periodontal therapy. Gingival tissue samples from periodontally healthy and gingivitis-affected subjects were obtained during tooth extractions for orthodontic reasons or crownlengthening procedures. The selected sites had no clinical attachment loss or radiographic evidence of bone loss. One tissue sample from each subject was obtained and was immediately submerged in a sterile tube containing 1 ml RNAlater solution (Ambion Inc, Austin, TX) and stored at +4°C overnight, before long term storage at -40°C until further laboratory analysis.
RNA i s o l a t i o n a n d Re v e r s e T r a n s c r i p t i o n
Total RNA from gingival tissue biopsies was extracted using the RiboPure RNA Isolation Kit (Ambion Inc, Austin, TX), and quantified using the NanoDrop ® ND-1000 spectophotometer. For the reverse transcription reaction, 1 µg of total RNA was incubated with 0.5 µg/ml of oligo dT primer at 70°C for 5 min and then cooled on ice.
A master mix was then added to samples, comprising of 200 units moloney murine leukemia virus (M-MLV) reverse transcriptase and buffer, and 10 mM PCR Nucleotide Mix (all from Promega). To obtain the single-stranded cDNA, these samples were then incubated at 40°C for 60 min, 70°C for 15 min, cooled down to +4°C for 5 min, and stored at -20°C until further use.
T a q Ma n ® q u a n t i t a t i v e r e a l -t i me P CR ( q P CR)
The expression levels of RANKL, NFATc1 and DC-STAMP were investigated by qPCR analysis (ABI Prism 7000 Sequence Detection System, Applied Biosystems).
The 18S rRNA was used as an endogenous RNA control in the samples. The standard PCR conditions for template amplification were 10 min at 95 º C, followed 40 cycles at This internal control has been efficiently used in the study of gene expression in gingival tissue biopsies (6).
S t a t i s t i c a l a n a l y s i s
Statistical analyses were performed using non-parametrical methods. Comparisons between all groups were performed using the Kruskal-Wallis test. When there were significant differences (p <0.05), comparisons between groups were assessed with Dunn's multiple comparison test. Correlations between RANKL and NFATc1 expression levels, or clinical parameters, were analysed by Spearman's rank correlation. All data analyses were performed using the GraphPad Prism Software 4.0.
RE S UL T S Cl i n i c a l f i n d i n g s o f s a mp l i n g s i t e s
The clinical parameters of the sampled sites are provided in Table 1 . The chronic and generalized aggressive periodontitis groups had significantly higher mean probing pocket depth and clinical attachment loss scores than the healthy and gingivitis groups (p <0.05). No significant differences were detected between gingivitis and periodontitis groups regarding the papilla bleeding index and plaque index of sampling sites (p >0.05).
RANKL a n d NF AT c 1 a n d DC-S T AMP g e n e e x p r e s s i o n a n a l y s i s b y q P CR
The levels of RANKL, NFATc1 and DC-STAMP gene expression in gingival tissues were evaluated by qPCR analysis. RANKL expression was detected in 4/10 healthy, (Fig. 2) . On the contrary, DC-STAMP expression was sparsely detected (0/0 health, 2/10 gingivitis, 2/18 chronic periodontitis, and 3/20 generalized aggressive periodontitis) among the tissue samples (Fig. 3) . Although numerically the relative DC-STAMP expression levels were higher in chronic and generalized aggressive periodontitis (1.13x10 5 and 0.66x10 5 , respectively) compared to gingivitis (0.13x10 5 ), the low detection frequency prohibited further statistical analyses.
In comparison to healthy tissues, both RANKL and NFATc1 expressions were higher in all three periodontal diseases groups. However, this difference proved to be significant in the cases of chronic and generalized aggressive periodontitis, but not in gingivitis. In particular, RANKL expression was higher by 35.6-fold in generalized aggressive periodontitis, 15.8-fold in chronic periodontitis, and 9.3-fold in gingivitis, respectively (Fig. 1) . In the case of NFATc1 expression, this was higher by 8.2-fold in generalized aggressive periodontitis, 6.0-fold in chronic periodontitis, and 3.7-fold in gingivitis, respectively (Fig. 2) . When the two periodontitis groups were compared, no statistically significant differences were found in RANKL or NFATc1 expression.
The Spearman's rank correlation analysis was then used to investigate the association between RANKL and NFATc1 expression levels in all groups (Fig. 4) . A strong positive correlation between the expression of these genes was revealed (r=0.846, p <0.0001).
Co r r e l a t i o n o f RANKL a n d NF AT c 1 g e n e e x p r e s s i o n wi t h c l i n i c a l p a r a me t e r s
Further analyses were performed in order to test whether there was an association of RANKL and NFATc1 expression levels with site-specific clinical parameters. For this purpose the Spearman's rank correlation analysis was used. The results indicated that the expression levels of both RANKL and NFATc1 were positively correlated (p < 0.01) with probing pocket depth, clinical attachment levels, papilla bleeding index and plaque index (Table 2) .
DI S CUS S I ON
The present study demonstrated that NFATc1 gene expression in gingival tissues is elevated by the severity of periodontal disease, with a significant enhancement in chronic and generalized aggressive periodontitis, compared to health. This could be of potential importance for the pathogenic mechanisms of periodontal disease, as antigenic stimulation of NFATc1 is known to activate the functions of T-cells (8, 9) .
Hence, increased NFATc1 expression may confirm the increased T-cell activity in periodontitis. However, since NFATc1 is also involved in osteoclastogenesis, the 
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F i g u r e 4
Scatter plot demonstrating a strong positive correlation between RANKL and NFATc1 gene expression in gingival tissues (r = 0.846, p < 0.0001).
